Cardiac valvular replacement in carcinoid heart disease

Area of Science:

• Cardiology
• Oncology
• Cardiac Surgery

Background:

• Carcinoid heart disease (CHD) is a rare complication of neuroendocrine tumors, often leading to significant valvular dysfunction.
• Tricuspid regurgitation is a common manifestation of CHD, impacting patient prognosis and quality of life.
• Surgical intervention for CHD, particularly early valve replacement, is less frequently reported.

Observation:

• A patient with symptomatic tricuspid regurgitation secondary to carcinoid heart disease was evaluated.
• The patient presented with symptoms attributable to the valvular involvement of CHD.
• Liver metastases from the carcinoid tumor were present but slowly growing.

Findings:

• Successful tricuspid valve replacement was performed in the symptomatic patient.
• The early surgical intervention allowed for prompt relief of valvular dysfunction.
• Post-operative recovery enabled the patient to resume a normal life, unhindered by cardiac symptoms.

Implications:

• This case underscores the potential benefit of early tricuspid valve replacement in select patients with carcinoid heart disease.
• Timely surgical management can significantly improve functional status and quality of life.
• Further investigation into the optimal timing of valve replacement in CHD is warranted.